FLUID Study Sub-investigator. A Phase IV, randomised, controlled, single masked study investigating the efficacy and safety of ranibizumab "inject and extend" using an intensive retinal fluid retreatment regimen compared to a relaxed retinal retreatment regimen in patients with wet age-related macular degeneration (AMD)

Project: Research

Project Details

StatusActive
Effective start/end date20/05/17 → …